Drugs / BIBP 5371 CL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02256709 | Apr → Aug 2004 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBP 5371 CL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02256709 ↗ |
| Route | Oral | “Following Oral Administration” NCT02256709 ↗ |